Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

Journal of Clinical Oncology

Volumn 29, Issue 13, 2011, Pages 1652-1654

  Burness, Monika L ^a   Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GADOLINIUM; TAMOXIFEN;

BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DISTRESS SYNDROME; EARLY DIAGNOSIS; EDITORIAL; ENDOMETRIUM CANCER; FALSE POSITIVE RESULT; GENE MUTATION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; OVARY CANCER; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; EARLY DETECTION OF CANCER; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASTECTOMY; MUTATION; RISK REDUCTION BEHAVIOR;

EID: 79955641237     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.5274     Document Type: Editorial

References (27)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994 (Pubitemid 24345325)
2. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994 (Pubitemid 24325690)
3. Palma M, Ristori E, Ricevuto E, et al: BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers. Crit Rev Oncol Hematol 57:1-23, 2006 (Pubitemid 41804077)
4. Narod SA, Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665-676, 2004
5. Brandberg Y, Sandelin K, Erikson S, et al: Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: A prospective 1-year follow-up study. J Clin Oncol 26:3943-3949, 2008
6. Kaas R, Verhoef S, Wesseling J, et al: Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: Very low risk for subsequent breast cancer. Ann Surg 251:488-492, 2010
7. Wainberg S, Husted J: Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 13:1989-1995, 2004
8. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97:1652-1662, 2005 (Pubitemid 41672231)
9. Rebbeck TR, Lynch HT, Neuhausen SL, et al: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622, 2002 (Pubitemid 34755669)
10. Warner E, Hill K, Causer P, et al: Prospective study of breast cancer incidence in womenwith a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 29:1664-1669, 2010
11. Kriege M, Brekelmans CT, Boetes C, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004
12. Benndorf M, Baltzer PA, Vag T, et al: Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes. Acta Radiol 51:715-721, 2010
13. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004 (Pubitemid 39223222)
14. Hagen AI, Kvistad KA, Maehle L, et al: Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 16:367-374, 2007 (Pubitemid 47157808)
15. Sardanelli F, Podo F, D'Agnolo G, et al: Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): Interim results. Radiology 242:698-715, 2007
16. Kurian AW, Sigal BM, Plevritis SK: Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol 28:222-231, 2010
17. Plevritis SK, Kurian AW, Sigal BM, et al: Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295:2374-2384, 2006 (Pubitemid 43788105)
18. Grann VR, Patel PR, Jacobson JS, et al: Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat [epub ahead of print on July 20, 2010]
19. Lehman CD, Schnall MD: Imaging in breast cancer: Magnetic resonance imaging. Breast Cancer Res 7:215-219, 2005 (Pubitemid 41387434)
20. Berg WA, Blume JD, Adams AM, et al: Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 254:79-87, 2010
21. Hoogerbrugge N, Kamm YJ, Bult P, et al: The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. Ann Oncol 19:655-659, 2008 (Pubitemid 351461034)
22. Bradbury A, Cummings S, Dignam J, et al: Anxiety and depression among high-risk women in an MRI surveillance study. 29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 14-17, 2006 (abstr 1065)
23. O'Neill SM, Rubinstein WS, Sener SF, et al: Psychological impact of recall in high-risk breast MRI screening. Breast Cancer Res Treat 115:365-371, 2009
24. Surveillance, Epidemiology, and End Results (SEER): Seer Stat Fact sheets: Breast. http://seer .cancer.gov
25. Foulkes WD, Wong N, Rozen F, et al: Survival of patients with breast cancer and BRCA1 mutations. Lancet 351:1359-1360, 1998 (Pubitemid 28195926)
26. Bonadona V, Dussart-Moser S, Voirin N, et al: Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review. Breast Cancer Res Treat 101:233-245, 2007 (Pubitemid 46115430)
27. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007 (Pubitemid 46535708)